XML 20 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Unaudited Condensed Consolidated Statement of Cash Flows Statement - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income $ 151,726 $ 185,329
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss on early extinguishment of debt, net (7,579) (10,131)
Depreciation and amortization 74,244 78,069
Amortization of intangibles 13,653 13,645
Amortization of cemetery property 33,523 29,813
Amortization of loan costs 2,989 3,017
Provision for doubtful accounts 4,273 4,494
Provision for deferred income taxes 6,090 22,011
Losses (gains) on divestitures and impairment charges, net 13,701 (7,347)
Gain (Loss) on Sale of Investments 0 (2,636)
Share-based compensation 8,013 7,544
Change in assets and liabilities, net of effects from acquisitions and divestitures:    
(Increase) decrease in receivables (11,608) 965
Increase in other assets (18,643) (10,635)
Decrease in payables and other liabilities (55,148) (37,817)
Effect of preneed production and maturities:    
Increase in preneed receivables, net and trust investments (1,594) (23,494)
Increase in deferred revenue, net 55,441 56,342
Decrease in deferred receipts held in trust (21,346) (14,055)
Net cash provided by operating activities 262,893 315,376
Cash flows from investing activities:    
Capital expenditures (112,714) (102,890)
Acquisitions, net of cash acquired (32,755) (167,622)
Payments to Acquire Businesses, Gross 32,800 35,600
Proceeds from divestitures and sales of property and equipment 11,380 18,305
Proceeds from Sale, Maturity and Collection of Investments 0 2,900
Payments on Company-owned life insurance policies (8,586) (11,733)
Proceeds from Company-owned life insurance policies 0 2,810
Other 0 (14,525)
Net cash used in investing activities (142,675) (272,755)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 854,263 370,000
Payments of Debt Issuance Costs 15,536 0
Scheduled payments of debt (8,712) (8,631)
Early payments of debt (828,121) (259,590)
Principal payments on finance leases 21,807 19,270
Proceeds from exercise of stock options 23,101 7,302
Purchase of Company common stock (29,574) (228,866)
Payments of dividends (65,691) (62,241)
Bank overdrafts and other 12,307 (8,820)
Net cash used in financing activities (79,770) (210,116)
Effect of foreign currency on cash, cash equivalents, and restricted cash 3,113 (2,133)
Net increase (decrease) in cash, cash equivalents, and restricted cash 43,561 (169,628)
Cash, cash equivalents, and restricted cash at beginning of period 207,584 340,601
Cash, cash equivalents, and restricted cash at end of period $ 251,145 $ 170,973